p53 mutant mice that display early ageing-associated phenotypes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53+/m) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53+/+) littermates. As p53+/m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in mice, chronically active p53 both promotes cellular senescence and accelerates aging phenotypes [ 31 , 32 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [32]
In the citing paper
“Cells from these modified mice were more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Evidence for this idea comes from the phenotype of genetically modified mice in which p53 function was enhanced either by low-level expression of an artificially truncated p53 protein (Tyner et al., 2002; Maier et al., 2004) or modest overexpression of a naturally occurring short isoform (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Delayed wound healing has been used as measure to characterize the aging phenotype of skin (170).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [170]
In the citing paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [18]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Self-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Research works printed but not linked: 3
- Arking, R. Biology of Aging 2nd edn 153–250 (Sinauer, Sunderland, Massachusetts, 1998).
- Chuttani, A. & Gilchrest, B. A. in Handbook of Physiology, Section 11: Aging (ed. Masoro, E. J.) 309–324 (Oxford Univ. Press, New York, 1995).
- Muravchik, S. in Clinical Anesthesia 3rd edn (eds Barash, P. G., Cullen, B. F. & Stoelting, R. K.) 1125–1136 (Lippincott-Raven, Philadelphia, 1997).
Cited by
Items 301–400 of 1,000
Microarray analysis of gene expression in the aging human retina.
Yoshida, S., Yashar, B. M., Hiriyanna, S., & Swaroop, A. (2002) · PubMed · Cited by 127
TPT1/ TCTP-regulated pathways in phenotypic reprogramming
Amson, R. B., Pece, S., Marine, J., Fiore, P. P. D., & Telerman, A. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.10.002 · Cited by 124
Yentrapalli, R., Azimzadeh, O., Barjaktarovic, Z., Sarioglu, H., Wojcik, A., Harms‐Ringdahl, M., Atkinson, M. J., Haghdoost, S., & Tapio, S. (2013) · PROTEOMICS · doi:10.1002/pmic.201200463 · Cited by 115
“In several mouse models, persistent low-level activation of p53, in response to constitutive stress such as DNA damage, leads to premature aging [36, 37].”
Backgroundp53-A natural cancer killer: Structural insights and therapeutic concepts
Römer, L., Klein, C., Dehner, A., Kessler, H., & Buchner, J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600611 · Cited by 93
Pathologies Associated with the p53 Response
Gudkov, A. V., & Komarova, E. A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001180 · Cited by 115
“Also, several knockout and transgenic mouse lines that showed increased p53 activity had premature aging phenotypes (Chin et al. 1999; Lim et al. 2000; Tyner et al. 2002; Cao et al. 2003; Wong et al. 2003; Varela et al. 2005).”
BackgroundCellular senescence: Its role in tumor suppression and aging
Ohtani, N., Mann, D. J., & Hara, E. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01123.x · Cited by 114
Puma is required for p53-induced depletion of adult stem cells
Liu, D., Ou, L., Clemenson, G. D., Chao, C., Lutske, M. E., Zambetti, G. P., Gage, F. H., & Xu, Y. (2010) · Nature Cell Biology · doi:10.1038/ncb2100 · Cited by 114
Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease
Gates, A. C., Bernal-Mizrachi, C., Chinault, S. L., Feng, C., Schneider, J. G., Coleman, T., Malone, J. P., Townsend, R. R., Chakravarthy, M. V., & Semenkovich, C. F. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.010 · Cited by 94
HERITABILITY OF NECTAR TRAITS: WHY DO WE KNOW SO LITTLE?
Mitchell, R. J. (2004) · Ecology · doi:10.1890/03-0388 · Cited by 114
“How- ever, experience with other traits (such as petal color; e.g., Glover and Martin 1998, Clegg and Durbin 2000, Irwin et al. 2003; see also Tyner et al. 2002) indicates that the effects of specific genes on labile physiological traits such as nectar will not be simple.”
BackgroundComprehensive transcriptional landscape of aging mouse liver
White, R. R., Milholland, B., MacRae, S. L., Lin, M., Zheng, D., & Vijg, J. (2015) · BMC Genomics · doi:10.1186/s12864-015-2061-8 · Cited by 113
“tain genes such as p53, Il7, Ctss, and NFκB, all of which have been previously associated with mammalian aging or senescence [23, 50, 51], and their age-related alterations may contribute to the most prevalent aging phenotype,”
BackgroundMrass, P., Rendl, M., Mildner, M., Gruber, F., Lengauer, B., Ballaun, C., Eckhart, L., & Tschachler, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1129 · Cited by 112
“mice with deletions of the p53 gene (18) nor mice overexpressing a mutant activated form of p53 (47) show epidermal abnormalities.”
BackgroundCaveolin-1, cellular senescence and age-related diseases
Zou, H., Stoppani, E., Volonte, D., & Galbiati, F. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.11.001 · Cited by 112
“Mouse models of gain of p53 function show increased tumor suppression but decreased longevity and early aging phenotypes (Maier et al., 2004; Tyner et al., 2002).”
BackgroundKominakis, A. P., Hager-Theodorides, A. L., Zoidis, E., Saridaki, A., Antonakos, G., & Tsiamis, G. (2017) · Genetics Selection Evolution · doi:10.1186/s12711-017-0316-3 · Cited by 134
Adipocytes in Skin Health and Disease
Rivera-Gonzalez, G., Shook, B., & Horsley, V. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015271 · Cited by 112
“Hair loss is associated with accelerated aging phenotypes in mouse models and normal aging in humans (Harrison and Archer 1988; Courtois et al. 1995; Tyner et al. 2002; Trüeb 2005; Kondratov et al. 2006; Geyfman and Andersen 2010).”
BackgroundmiR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal
Herrera-Merchan, A., Cerrato, C., Luengo, G., Dominguez, O., Piris, M. A., Serrano, M., & Gonzalez, S. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12598 · Cited by 110
“Transplantation assays have demonstrated that the constitutively high p53 activity induces a decreased HSC self-renewal capacity,(15) which may thus contribute to accelerated aging.(9) However, mice with one extra copy of genomic p53 (“super-p53,” hereafter sp53) age normally, despite showing enhanced responses to DNA…”
BackgroundInfluentialPlecitá‐Hlavatá, L., Aguilaniu, H., Pichová, A., & Nyström, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg314 · Cited by 118
Pathology of mouse models of accelerated aging
Harkema, L., Youssef, S. A., & de Bruin, A. (2016) · Veterinary Pathology · doi:10.1177/0300985815625169 · Cited by 105
p53 targets identified by protein expression profiling
Rahman-Roblick, R., Roblick, U. J., Hellman, U., Conrotto, P., Liu, T., Becker, S., Hirschberg, D., Jörnvall, H., Auer, G., & Wiman, K. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700794104 · Cited by 120
Manganese Superoxide Dismutase Induces p53-Dependent Senescence in Colorectal Cancer Cells
Behrend, L., Mohr, A., Dick, T., & Zwacka, R. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7758-7769.2005 · Cited by 109
“Intriguingly, a transgenic mouse which carries an activated p53 shows an earlyaging phenotype and enhanced tumor resistance, consistent with the idea that p53 controls senescence as a mechanism of tumor suppression (44).”
BackgroundKou, X., Liu, X., Chen, X., Li, J., Yang, X., Fan, J., Yang, Y., & Chen, N. (2016) · Oncotarget · doi:10.18632/oncotarget.12811 · Cited by 108
“Many factors inducing senescence can activate p53 signal pathway and promote cellular senescence [22].”
BackgroundMyocardial Aging and Senescence: Where Have the Stem Cells Gone?
Sussman, M. A., & Anversa, P. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032102.140723 · Cited by 108
Aging, anti-aging, and hormesis
Rattan, S. I. S. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.01.006 · Cited by 121
The Influence of Genes on the Aging Process of Mice
de Magalhães, J. P., Cabral, J. A. S., & Magalhães, D. (2005) · Genetics · doi:10.1534/genetics.104.032292 · Cited by 106
Scarless wound healing: From development to senescence
Pratsinis, H., Mavrogonatou, E., & Kletsas, D. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.011 · Cited by 103
Lander, E. S. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1506446 · Cited by 108
The Clinical Relevance of Hyperkyphosis: A Narrative Review
Koelé, M. C., Lems, W. F., & Willems, H. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00005 · Cited by 136
“Mouse knock-out and transgenic models show that hyperkyphosis may be enhanced by mutations in the genes involved in DNA repair and delaying senescence (49, 50).”
BackgroundAnti‐aging activity of the Ink4/Arf locus
Matheu, A., Maraver, A., Collado, M., Garcia‐Cao, I., Cañamero, M., Borras, C., Flores, J. M., Klatt, P., Viña, J., & Serrano, M. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00458.x · Cited by 94
“First, male sterility has not been reported for a variety of genetic modifications that upregulate p53 (Garcia-Cao et al., 2002; Tyner et al., 2002; Matheu et al., 2004; Mendrysa et al., 2006; Matheu et al., 2007), although there is one exception (Maier et al., 2004).”
BackgroundZhu, X., Yu, Q.-S., Cutler, R. G., Culmsee, C. W., Holloway, H. W., Lahiri, D. K., Mattson, M. P., & Greig, N. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020044d · Cited by 106
Bartholomew, J. N., Volonte, D., & Galbiati, F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2857 · Cited by 106
“of gain of p53 function show increased tumor suppression but decreased longevity and early aging phenotypes (29, 30).”
BackgroundThe Sirt1 deacetylase modulates the insulin-like growth factor signaling pathway in mammals
Lemieux, M. E., Yang, X. M., Jardine, K. E., He, X., Jacobsen, K. X., Staines, W. A., Harper, M., & McBurney, M. W. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.04.006 · Cited by 112
Molecular biology of pyridine nucleotide and nicotine biosynthesis
Katoh, A. (2004) · Frontiers in Bioscience · doi:10.2741/1350 · Cited by 106
“lengthens the lifespan of the worm (8); and a human homologue SIRT1 promotes cell survival by negatively regulating the p53 tumor suppressor (11).”
Backgroundde Magalhães, J. P. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.006 · Cited by 124
“Of course that these are mostly disruptive changes, so maybe other types of interventions affect ageing and not solely cancer, as demonstrated with p53 [109].”
BackgroundInfluentialQin, J., Chaturvedi, V., Denning, M. F., Bacon, P. E., Panella, J., Choubey, D., & Nickoloff, B. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205404 · Cited by 113
“Along this line of inquiry, a recent report in which transgenic mice with mutant p53, rendering it constitutively active, were observed to undergo premature aging in several organ systems (Tyner et al., 2002).”
BackgroundRuzankina, Y., Schoppy, D. W., Asare, A., Clark, C. E., Vonderheide, R. H., & Brown, E. J. (2009) · Nature Genetics · doi:10.1038/ng.441 · Cited by 97
p53 activates ICAM‐1 (CD54) expression in an NF‐κB‐independent manner
Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Kletsas, D., Mariatos, G., Zoumpourlis, V., Ryan, K. M., Kittas, C. N., & Papavassiliou, A. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg157 · Cited by 112
Lee, S. M., Kim, J., Cho, E., & Youn, H. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.5 · Cited by 116
Begus-Nahrmann, Y., Lechel, A., Obenauf, A. C., Nalapareddy, K., Peit, E., Hoffmann, E., Schlaudraff, F., Liss, B., Schirmacher, P., Kestler, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.426 · Cited by 88
Running Forward: New Frontiers in Endurance Exercise Biology
Rowe, G. C., Safdar, A., & Arany, Z. (2014) · Circulation · doi:10.1161/circulationaha.113.001590 · Cited by 103
“Similarly, mice engineered with hyperactive p53 alleles also display premature aging.(174) Exercise appears to favorably affect these processes as well, but again the mechanisms are not clear.”
Encinas, J. M., & Sierra, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.010 · Cited by 119
Cellular lifespan and senescence signaling in embryonic stem cells
Miura, T., Mattson, M. P., & Rao, M. S. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00134.x · Cited by 102
“This mutant mouse, the p53+/m mouse, shows reduced longevity and an early onset of phenotypes associated with aging, including organ atrophy and a reduced regenerative response (Tyner et al., 2002), suggesting that stem cell function could be an important component of these phenotypes.”
BackgroundIncreased p53 activity does not accelerate telomere‐driven ageing
García‐Cao, I., García‐Cao, M., Tomás‐Loba, A., Martin‐Caballero, J., Flores, J. M., Klatt, P., Blasco, M. A., & Serrano, M. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400667 · Cited by 102
Minamino, T., & Komuro, I. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1324 · Cited by 109
Regulation of lifespan by histone deacetylase
Chang, K. T., & Min, K.-T. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(02)00003-x · Cited by 102
Corrado, A., Cici, D., Rotondo, C., Maruotti, N., & Cantatore, F. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103679 · Cited by 114
“In murine models of premature aging and features of oxidative stress, osteoporotic fractures are observed [91].”
BackgroundTian, X., Azpurua, J., Ke, Z., Augereau, A., Zhang, Z. D., Vijg, J., Gladyshev, V. N., Gorbunova, V., & Seluanov, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418203112 · Cited by 101
“For example, overly zealous tumor suppression, such as that observed in mice with an overactive p53 gene (45, 46), may limit stem-cell reserves and lead to premature aging; and very loose tumor suppression would also shorten lifespan by increasing cancer incidence.”
BackgroundDoes Damage to DNA and Other Macromolecules Play a Role in Aging? If So, How?
Campisi, J., & Vijg, J. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gln065 · Cited by 101
Bauer, J. H., Poon, P. C., Glatt-Deeley, H., Abrams, J. M., & Helfand, S. L. (2005) · Current Biology · doi:10.1016/j.cub.2005.10.051 · Cited by 100
“Mice with increased expression of the 24 kDa or 44 kDa forms of p53 are resistant to tumor formation, but unexpectedly have a shortened life span with premature development of a number of phenotypes associated with aging [1, 2].”
BackgroundGreer, E. L., & Brunet, A. (2008) · Journal of Cell Science · doi:10.1242/jcs.021519 · Cited by 118
“For example, a mouse mutant that has constitutively activated p53 develops fewer tumors but also shows signs of rapid aging (Tyner et al., 2002).”
BackgroundWeinstein, B. S., & Ciszek, D. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00012-8 · Cited by 109
Transposon-triggered innate immune response confers cancer resistance to the blind mole rat
Zhao, Y., Oreskovic, E., Zhang, Q., Lu, Q., Gilman, A., Lin, Y. S., He, J., Zheng, Z., Lu, J. Y., Lee, J., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01027-8 · Cited by 99
Male age, germline mutations and the benefits of polyandry
Radwan, J. (2003) · Ecology Letters · doi:10.1046/j.1461-0248.2003.00484.x · Cited by 105
Progeria of Stem Cells: Stem Cell Exhaustion in Hutchinson-Gilford Progeria Syndrome
Halaschek-Wiener, J., & Brooks-Wilson, A. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.1.3 · Cited by 98
GREIG, N. H., MATTSON, M. P., PERRY, T., CHAN, S. L., GIORDANO, T., SAMBAMURTI, K., ROGERS, J. T., OVADIA, H., & LAHIRI, D. K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.018 · Cited by 98
Negative reciprocal regulation between Sirt1 and Per2 modulates the circadian clock and aging
Wang, R.-H., Zhao, T., Cui, K., Hu, G., Chen, Q., Chen, W., Wang, X.-W., Soto-Gutierrez, A., Zhao, K., & Deng, C.-X. (2016) · Scientific Reports · doi:10.1038/srep28633 · Cited by 98
Kirschner, K., Chandra, T., Kiselev, V., Flores-Santa Cruz, D., Macaulay, I. C., Park, H. J., Li, J., Kent, D. G., Kumar, R., Pask, D. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.074 · Cited by 100
“Observations from studies in progeroid and hyperactivated p53mousemodels suggest amore generalized role for p53, possibly extending the relevance of our findings to nonhematopoietic tissues (Varela et al., 2005; Tyner et al., 2002).”
BackgroundA forkhead in the road to longevity: the molecular basis of lifespan becomes clearer
Morris, B. J. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000173509.45363.dd · Cited by 98
Improving cancer therapy by non-genotoxic activation of p53
Laín, S., & Lane, D. P. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00063-7 · Cited by 106
“Accordingly, Donehower and colleagues [75] have observed that a constitutive increase in p53 activity is associated with the appearance of very clear symptoms of premature ageing in mice.”
BackgroundEndothelial cell senescence and thrombosis: Ageing clots
Bochenek, M. L., Schütz, E., & Schäfer, K. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.09.019 · Cited by 96
Molecular Regulation of Melanocyte Senescence
Bennett, D. C., & Medrano, E. E. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.02036.x · Cited by 95
Caspase-2 deficiency enhances aging-related traits in mice
Zhang, Y., Padalecki, S. S., CHAUDHURI, A., deWaal, E., Goins, B., Grubbs, B. G., Ikeno, Y., Richardson, A. G., MUNDY, G., & HERMAN, B. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.030 · Cited by 104
“…biological marker of aging, the change of aging rate is always assessed by examining the animal's lifespan together with a number of aging-dependent traits, most important of which are skeletal health, hair growth and subcutaneous fat content (Tyner et al., 2002; Trifunovic et al., 2004).”
BackgroundInfluentialUnleashing the power of p53: lessons from mice and men: Figure 1.
Poyurovsky, M. V., & Prives, C. (2006) · Genes & Development · doi:10.1101/gad.1397506 · Cited by 96
p53 at the crossroads between cancer and neurodegeneration
Lanni, C., Racchi, M., Memo, M., Govoni, S., & Uberti, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.034 · Cited by 95
New tricks of an old molecule: lifespan regulation by p53
Bauer, J. H., & Helfand, S. L. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00228.x · Cited by 106
The Role of Thioredoxin in the Aging Process: Involvement of Oxidative Stress
Yoshida, T., Oka, S., Masutani, H., Nakamura, H., & Yodoi, J. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770310211 · Cited by 103
“…of the loci; ND, not described in detail or ineffective effect by locus alone. been identified to show shorter life spans if continuous cellular proliferation is inhibited by DNA damage (11), DNA repair defects (10, 64, 70), enhanced apoptosis (62), or decreased telomere length (17, 66) (Table 3).”
mTORC1 and p53: Clash of the gods?
Hasty, P., Sharp, Z. D., Curiel, T. J., & Campisi, J. (2013) · Cell Cycle · doi:10.4161/cc.22912 · Cited by 94
The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element
Vilborg, A., Glahder, J. A., Wilhelm, M., Bersani, C., Corcoran, M., Mahmoudi, S., Rosenstierne, M. W., Grandér, D., Farnebo, M., Norrild, B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900862106 · Cited by 94
“There is also evidence from in vivo models that overactive p53 can cause premature aging (5).”
BackgroundKlotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway
de Oliveira, R. M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.036 · Cited by 94
The relationship between aging and carcinogenesis: a critical appraisal
Anisimov, V. N. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00121-x · Cited by 111
FoxO1 is involved in the antineoplastic effect of calorie restriction
Yamaza, H., Komatsu, T., Wakita, S., Kijogi, C., Park, S., Hayashi, H., Chiba, T., Mori, R., Furuyama, T., Mori, N., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00563.x · Cited by 93
Self-citationNucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization
Saxena, A. D., Rorie, C. J., Dimitrova, D. D., Daniely, Y., & Borowiec, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209714 · Cited by 105
“One hypermorphic p53 mutant, although decreasing the susceptibility to tumor development, results in reduced longevity (Tyner et al., 2002).”
BackgroundThe Flavoring Agent Dihydrocoumarin Reverses Epigenetic Silencing and Inhibits Sirtuin Deacetylases
Olaharski, A. J., Rine, J., Marshall, B. L., Babiarz, J., Zhang, L., Verdin, E., & Smith, M. T. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010077 · Cited by 93
Aging as a Mitochondria‐Mediated Atavistic Program: Can Aging Be Switched Off?
SKULACHEV, V. P., & LONGO, V. D. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1356.009 · Cited by 93
p73 Regulates Neurodegeneration and Phospho-Tau Accumulation during Aging and Alzheimer's Disease
Wetzel, M. K., Naska, S., Laliberté, C. L., Rymar, V. V., Fujitani, M., Biernaskie, J., Cole, C. J., Lerch, J. P., Spring, S., Wang, S., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.07.021 · Cited by 104
“In this regard, the tumor suppressor p53 and its family member, p63, have been implicated in aging outside of the nervous system; mouse models with enhanced p53 activity display accelerated aging and decreased lifespan (Tyner et al., 2002; Lavigueur et al., 1989; Maier et al., 2004), and aging is enhanced in p63 mice…”
BackgroundZhao, Y., Tyshkovskiy, A., Muñoz-Espín, D., Tian, X., Serrano, M., de Magalhaes, J. P., Nevo, E., Gladyshev, V. N., Seluanov, A., & Gorbunova, V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721160115 · Cited by 92
“However, too much apoptosis may deplete stem-cell reserves and contribute to frailty in old age (35, 36).”
BackgroundPolymorphic variants in the p53 pathway
Murphy, M. E. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401907 · Cited by 101
The p53 tumor suppressor protein regulates hematopoietic stem cell fate
Asai, T., Liu, Y., Bae, N., & Nimer, S. D. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22561 · Cited by 111
“Knock-in mice expressing a truncated but active form of p53 (p53þ/m) exhibit an early aging phenotype with fewer proliferating HSCs compared with older wild-type mice (Tyner et al., 2002; Maier et al., 2004). p53þ/ mice, that have slightly reduced p53 levels, show the opposite phenotype.”
BackgroundLiu, S., Liu, S., Wang, X., Zhou, J., Cao, Y., Wang, F., & Duan, E. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00704.x · Cited by 90
“…Society of Great Britain and Ireland 670 Noteworthily, recent studies using gene knockout mice revealed that the loss of some negative regulators of cell cycle, such as p53, actually induced overall aging because of accelerated cell division and premature cell depletion (Tyner et al., 2002).”
BackgroundEndogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development
Naser, R., Aldehaiman, A., Díaz-Galicia, E., & Arold, S. T. (2018) · Cancers · doi:10.3390/cancers10060196 · Cited by 90
“While loss or damage of p53 is closely associated with the development of tumors, forced overexpression can cause premature aging [145].”
BackgroundImmunity and cognition: what do age-related dementia, HIV-dementia and ‘chemo-brain’ have in common?
Kipnis, J., Derecki, N. C., Yang, C., & Scrable, H. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.007 · Cited by 90
TAp73 Acts via the bHLH Hey2 to Promote Long-Term Maintenance of Neural Precursors
Fujitani, M., Cancino, G. I., Dugani, S. B., Weaver, I. C. G., Gauthier-Fisher, A., Paquin, A., Mak, T. W., Wojtowicz, M. J., Miller, F. D., & Kaplan, D. R. (2010) · Current Biology · doi:10.1016/j.cub.2010.10.029 · Cited by 89
“Both proteins regulate organismal aging [2–4] aswell as survival and self-renewal of tissue stem cells [5–9].”
The Regulation of Aging and Longevity: A New and Complex Role of p53
Feng, Z., Lin, M., & Wu, R. (2011) · Genes & Cancer · doi:10.1177/1947601911410223 · Cited by 89
“Although the p53+/m mice were resistant to spontaneous cancers, the mice displayed a shortened life span (decreased by 20%-30%) and premature aging phenotypes, including organ atrophy, skin atrophy, osteoporosis, and reduced tolerance to stresses.(21) These effects of mutant p53 protein were dependent on the presence…”
BackgroundIn vivo analysis of p53 tumor suppressor function using genetically engineered mouse models
Broz, D. K., & Attardi, L. D. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp331 · Cited by 67
‘Accelerated aging’: a primrose path to insight?
Miller, R. A. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00081.x · Cited by 87
“Compared with normal aged mice (see right panel) the mutant shows dramatic loss of adiposity and muscle mass and pronounced kyphosis of the spine (Tyner et al., 2002).”
Backgroundp53/MDM2 signaling pathway in aging, senescence and tumorigenesis
Huang, Y., Che, X., Wang, P. W., & Qu, X. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.001 · Cited by 94
Cutaneous wound healing in aging small mammals: a systematic review
Kim, D. J., Mustoe, T. A., & Clark, R. A. F. (2015) · Wound Repair and Regeneration · doi:10.1111/wrr.12290 · Cited by 101
Should I stay or should I go: β-catenin decides under stress
Hoogeboom, D., & Burgering, B. M. T. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.02.002 · Cited by 106
Cell-specific responses to loss of cyclin-dependent kinases
Berthet, C., & Kaldis, P. (2007) · Oncogene · doi:10.1038/sj.onc.1210243 · Cited by 97
“Disturbance of this delicate equilibrium can induce premature senescence, as suggested by the study of a hypermorphic p53 mutant mouse resulting in reduced longevity and an early onset of an aging phenotype (Tyner et al., 2002).”
BackgroundGannon, H. S., Donehower, L. A., Lyle, S., & Jones, S. N. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.02.007 · Cited by 87
“The procedure for this assay was modified from a previously described protocol (Tyner et al., 2002).”
BackgroundMethodResultSelf-citationRichardson, R. B., Allan, D. S., & Le, Y. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.03.015 · Cited by 87
“On the other hand, mice with increased p53 activity had a cancer incidence only 1/8th that of normal mice, yet aged prematurely, with a 23% reduction in median lifespan (Tyner et al., 2002).”
Vo, N. N., Niedernhofer, L. J., Nasto, L. A., Jacobs, L. J., Robbins, P. D., Kang, J. D., & Evans, C. H. (2013) · Journal of Orthopaedic Research® · doi:10.1002/jor.22204 · Cited by 90
“Mice expressing mutant p53, a key regulator of the cellular response to genotoxic stress, exhibit premature aging and significant osteopenia, causing suppression of both bone formation and resorption.(61) A knockout mouse for the ataxia telangiectasia mutated (Atm) gene is also recognized as a model of premature aging…”
BackgroundReplicative senescence revisited.
Marcotte, R., & Wang, E. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.b257 · Cited by 86
“activity of the remaining wild type allele showed decreases in both tumor incidence and life span (178).”
BackgroundVecchio, G., Galeone, A., Brunetti, V., Maiorano, G., Sabella, S., Cingolani, R., & Pompa, P. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029980 · Cited by 98
Cellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 94
Formation of Disulfide Bond in p53 Correlates with Inhibition of DNA Binding and Tetramerization
Sun, X. Z., Vinci, C., Makmura, L., Han, S., Tran, D., Nguyen, J., Hamann, M., Grazziani, S., Sheppard, S., Gutova, M., et al. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603770310338 · Cited by 86
YOSHIDA, T., NAKAMURA, H., MASUTANI, H., & YODOI, J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1323.002 · Cited by 86
Connecting autophagy to senescence in pathophysiology
Young, A. R. J., & Narita, M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.005 · Cited by 107
Pehar, M., O’Riordan, K. J., Burns‐Cusato, M., Andrzejewski, M. E., Del Alcazar, C. G., Burger, C., Scrable, H., & Puglielli, L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00547.x · Cited by 86
“In genetically altered mice, truncation of the N-terminus of full-length p53 (p53 ⁄ m mice) (Tyner et al., 2002) or increased dosage of D40p53 (p44 ⁄ + mice) (Maier et al.”
BackgroundDysfunction of the MDM2/p53 axis is linked to premature aging
Lessel, D., Wu, D., Trujillo, C., Ramezani, T., Lessel, I., Alwasiyah, M. K., Saha, B., Hisama, F. M., Rading, K., Goebel, I., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92171 · Cited by 86
“Two studies involving mice with N-terminal truncated p53 in the presence of functional WT p53 revealed accelerated aging phenotypes (19, 20).”
Untergasser, G., Koch, H., Menssen, A., & Hermeking, H. (2002) · PubMed · Cited by 99
Pereira, S., Bourgeois, P., Navarro, C., Esteves-Vieira, V., Cau, P., De Sandre-Giovannoli, A., & Lévy, N. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.003 · Cited by 85
“…links existing between altered bone development, DNA repair, accelerated aging, and reduced cancer are the phenotypes of several DNA repair mouse models, as XPD mutant mice (de Boer et al., 2002), Ku80 defective mice (Difilippantonio et al., 2000) and p53 truncation mutants (Tyner et al., 2002).”
Metadata
- Authors
- Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- University of Massachusetts Chan Medical School (US)
- Leibniz Institute of Virology (LIV) (DE)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Nature
- Published
- 2002-01
- Volume
- 415
- Issue
- 6867
- Pages
- 45-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2171317581
- Cited by
- 1,459
- References
- 42
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 41 · 2022: 30 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 52 · 2015: 52 · 2014: 60 · 2013: 64 · 2012: 69
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, aging, longevity, osteoporosis, organ atrophy, stress tolerance, transgenic mice, apoptosis, cellular senescence
- MeSH terms
- Adipose Tissue, Aging, Alleles, Animals, Body Weight, Bone and Bones, Cell Transformation, Neoplastic, Cells, Cultured, Exons, Female, Hair, Longevity, Male, Mice, Transgenic, Neoplasms, Organ Size, Osteoporosis, Phenotype, RNA, Messenger, Skin, Wound Healing, Genes, p53, Tumor Suppressor Protein p53, Sequence Deletion, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.